Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KANG FU PEN for radiation-induced rectal injury in cervical cancer
NCT04819685Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2021
- Primary completion
- Mar 2023
- Modality
- Animal-derived Natural Products, TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of kangfuxin in radiation-induced rectal injury, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
kangfuxin
03
Conditions
radiation-induced rectal injury
Beyond the preview
Go deeper on NCT04819685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04819685.